Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

DHPG

Copy Product Info
🥰Excellent
Catalog No. T11032Cas No. 146255-66-5
Alias (RS)-3,5-DHPG

DHPG ((RS)-3,5-DHPG) is an effective antagonist of mGluR linked to phospholipase D. As an amino acid, it serves as a selective and potent agonist for Group I mGluR (mGluR 1 and mGluR 5) without affecting Group II or Group III mGluRs.

DHPG

DHPG

Copy Product Info
🥰Excellent
Purity: 99.55%
Catalog No. T11032Alias (RS)-3,5-DHPGCas No. 146255-66-5
DHPG ((RS)-3,5-DHPG) is an effective antagonist of mGluR linked to phospholipase D. As an amino acid, it serves as a selective and potent agonist for Group I mGluR (mGluR 1 and mGluR 5) without affecting Group II or Group III mGluRs.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$43In StockIn Stock
10 mg$68In StockIn Stock
25 mg$127In Stock-
50 mg$231In Stock-
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.55%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

DHPG AI Summary
DHPG exhibits a range of inhibitory bioactivities across various targets and assays. It inhibits RecQ-Like DNA Helicase 1 (RECQ1) with a potency of 39810.7 nM, Aldehyde Dehydrogenase 1 (ALDH1A1) at 37650.5 nM, and Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) at 39810.7 nM. It is also involved in identifying cell-membrane-permeable IMPase inhibitors potentiated with lithium, showing a potency of 5011.9 nM. Additionally, it blocks the interaction between CBF-beta and RUNX1, relevant for the treatment of Acute Myeloid Leukemia, with an inhibition potency of 39810.7 nM. DHPG further inhibits the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) at 39810.7 nM. In assays on rat hippocampal astrocytes, this compound inhibits ASCT2 mediated [3H]-D-serine uptake by equal to or greater than 25.0% at a concentration of 1 mM after 5 minutes. Lastly, it demonstrates inhibitory activity on human HDAC6, with inhibition percentages of 9.39% for a commercial peptide substrate and 5.3% for a custom peptide substrate..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
DHPG ((RS)-3,5-DHPG) is an effective antagonist of mGluR linked to phospholipase D. As an amino acid, it serves as a selective and potent agonist for Group I mGluR (mGluR 1 and mGluR 5) without affecting Group II or Group III mGluRs.
Synonyms(RS)-3,5-DHPG
Chemical Properties
Molecular Weight183.16
FormulaC8H9NO4
Cas No.146255-66-5
SmilesO=C(C(C1=CC(O)=CC(O)=C1)N)O
Relative Density.1.55g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 1 mg/mL (5.46 mM), Sonication is recommended.
H2O: 1 mg/mL (5.46 mM), Sonication is recommended.
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM5.4597 mL27.2985 mL54.5971 mL272.9854 mL
5 mM1.0919 mL5.4597 mL10.9194 mL54.5971 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DHPG | purchase DHPG | DHPG cost | order DHPG | DHPG chemical structure | DHPG formula | DHPG molecular weight